The FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s Visudyne photodynamic therapy for the treatment of classic subfoveal choroidal neovascularization due to age-related macular degeneration.
According to a press release from Bausch + Lomb and Modulight, the ML6710i is a transportable ophthalmic laser that is controlled using an iPad mobile application. The laser’s beam shaping unit can be fit into common slit lamps and formed into a circular, uniform spot for Visudyne (verteporfin for injection) delivery.
“PDT continues to be an